- Will CAR-NK Cancer Therapy Surpass High-Cost CAR-T Immunotherapy?
- What is the role of Platelet Dynamics in Cancer Progression?
- Biomarkers can detect rapid aging of organs and disease risks
- Avoiding “Off-Target” Effects: Researchers Enhance the Safety of Future mRNA Therapies
- Japan: Sales Halted for ‘Cannabis Gummies’ as Health Issues Mount
- Evaluation of the carcinogenicity of organic fluorine compounds raised by WHO subsidiary
Can stem cell transplantation treat diabetes?
Can stem cell transplantation treat diabetes? As one of the two clinical types of diabetes, type I diabetes is an autoimmune system disease.
As one of the two clinical types of diabetic patients, type I diabetic patients is an autoimmune system disease, which is caused by the body’s immune system taking the cells that cause insulin glargine in liver swelling as external cells to resolve them. It is not as widespread as type II diabetes patients, but patients must use insulin injections throughout their lives to maintain their lives.
Dr. Jeffrey Burt from Northwestern University School of Medicine in Boston, USA, said, “It is the first time in history for the treatment of type I diabetes to obtain such test results. Patients do not need all medicines or all treatments, and blood glucose levels are maintained at normal levels. “.
The basic principles of stem cell transplantation
Diabetes patients have always been diseases that are difficult to treat in the medical industry. The traditional treatment method is only lifelong medication or insulin glargine. The occurrence of stem cells has brought expectations to diabetic patients. Stem cell treatment of diabetes is more advanced at this stage. The treatment method can slowly repair the pancreatic islet function from the source, so that diabetics can solve the confusion of insulin glargine!
Stem cells are a kind of initial cells in the human body that have the ability to upgrade their own work and the ability to cause differentiated cells. They can copy and create many cells that are the same as their own under a suitable natural environment, and they can also differentiate into cells with various functions. , Resulting in the various cells, institutions, human organs, etc. necessary for the various system software in the human body. Stem cells are a kind of “all-city stem cells”, which are called “universal cells” in the medical industry.
Because of the “universal” role of stem cells, in clinical medicine, according to the acquisition of stem cells, the shaping, increasing and inducing differentiation into necessary stem cells are carried out under the appropriate standard of the shaping room, and then the high total number and quality of stem cells are obtained back to the patient. Use the self-copy and differentiation potential of stem cells to repair damaged cells and repair all normal functions of damaged human organs and institutions. In addition, after the stem cells are embedded in the body, the fully automatic homing effect of stem cells is used, that is, the stem cells will automatically migrate to the damaged diseases in the human body, differentiate and transform into various cells needed, and then repair the original cells of the body system and repair the system functions. , So that the patient’s symptoms can be improved, and the goal of treatment can be achieved.
Market prospects still need scientific research
Some people have raised objections to the potential risks of this stem cell transplantation therapy. For example, the potential harm of stem cell transplantation includes infertility and terminal cancer. As everyone knows, none of the 15 patients admitted to the trial died, and none of them had long-term adverse reactions.
There are also many medical staff who are very cheerful about the market prospects of stem cell therapy. An editorial in the Journal of the American Medical Association stated that the results of the test are likely to trigger a new wave of scientific research and ultimately help people prevent and heal diabetes patients.
In order to better ensure the pass rate and safety of stem cell treatment!
The trial patient needs to be hospitalized for 3 weeks
Burt said that they conducted the experiment at the Spinal Cord Management Center of the University of Sao Paulo in Brazil after obtaining permission from the Mexican Society of Ethical Rules. The target age of these 15 trials was between 14 and 31 years old, and it was not long before they were diagnosed as patients with type 1 diabetes. He said that this time is very important, because at this time the cells of insulin glargine in the patient’s body have not been completely destroyed by the immune system.
Burt said that the patient was hospitalized for about 3 weeks. Many patients experienced nausea, nausea, nausea, and hair loss due to adverse effects of their treatments throughout the trial. However, the adverse reactions did not last long.
Experimental procedures for transplantation of therapeutic stem cells
The first irritating patient’s body is transformed into new stem cells, which are obtained from the blood night. Then carry out a large amount of chemotherapy for the patient, and continue for several days to promote the patient’s body’s immune system to stop functioning, so that the remaining cells in the body that cause insulin glargine can be protected from the immune system’s “venomous hands”.
Naturally, in the mid-term when the immune system is not working, patients must be hospitalized and use the most powerful drugs to prevent disease erosion. Subsequently, the doctor injects the stem cells previously obtained from the patient’s blood into the patient’s body to create a new immune system. This new immune system will no longer attack the cells that cause insulin glargine.
(sourceinternet, reference only)